Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 16 Nasopharyngeal Carcinoma 7 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Nasopharyngeal Neoplasms 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Recurrence 2 Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Squamous Non-small Cell Lung Cancer 1 Squamous Non-Small Cell Lung Cancer SqNSCLC 1 Solid Tumors 1 Sarcoma 1 Optic Nerve Glioma 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neuroblastoma 1 Meningeal Carcinomatosis 1 Melanoma 1 Lymphoma, T-Cell 1 Locally Advanced Squamous Non-small Cell Lung Cancer 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Cancer Organoids 1 Advanced Pancreatic Cancer 1

Interventions

Carboplatin 8 Filgrastim 6 Temozolomide 5 Etoposide 5 etoposide phosphate 3 Vincristine 3 Radiotherapy 3 Peripheral Blood Stem Cell Transplantation 3 Melphalan 2 Magnetic Resonance Spectroscopy 2 Ifosfamide 2 Granulocyte Colony-Stimulating Factor 2 Cyproheptadine 2 Cyclophosphamide 2 Busulfan 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 trioctyl phosphine oxide 1 sodium thiosulfate 1 sargramostim 1 gallium Ga 68 dotatate 1 fluorodopa F 18 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Transplantation 1 Topotecan 1 Thiotepa 1 Stem Cell Transplantation 1 Radiotherapy, Intensity-Modulated 1 Photochemotherapy 1 Perfusion Magnetic Resonance Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Optic Nerve Glioma × Endostatins × Clear all

NCT05278715 2024-10-15

Modified CV Regimen in Optic Pathway Glioma

Beijing Sanbo Brain Hospital

Phase 2 Recruiting

Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡